Sofinnova Investments' Jakob Dupont on the private markets in biotech
Jakob Dupont says he is focused on clinical stage companies or ones that are months within IND. He thinks the IPO market will be available for advanced companies in 2024.
Also look for unique social pages for BiotechTV U.
Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium rental lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.